US81642T2096
US81642T2096
SELLAS Life Sciences Group, Inc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 28.274.000 | 31.513.000 | 10.3% | |
| Operating Income | -28.274.000 | -31.513.000 | 10.3% |
| Pretax Income | -26.863.000 | -30.881.000 | 13.0% |
| Net Income Common Stockholders | -26.863.000 | -30.881.000 | 13.0% |
| -- | -- | -- | |
| -- | -- | -- |